AGR2 and hepatocellular carcinoma: Furthermore, we intend to investigate the AGR2 levels in patients treated with and without sorafenib to analyze the ratio of AGR2 levels under both conditions, which might provide a precise ratio for chemotherapy outcomes and aid in determining the clinical prognosis of patients with HCC.